Deruxtecan is a potent chemotherapeutic payload utilized as a key component in antibody-drug conjugates, most notably in therapies designed to treat various solid tumors including breast and non-small… Read more
Deruxtecan is a potent chemotherapeutic payload utilized as a key component in antibody-drug conjugates, most notably in therapies designed to treat various solid tumors including breast and non-small cell lung cancers. As an essential element of these complex biotherapeutics, Deruxtecan and its derivatives are critical in pharmaceutical research and manufacturing. This category provides high-quality reference standards of the active pharmaceutical ingredient, alongside its defined impurities, such as N-oxide and stereoisomers, and stable isotope-labelled versions. Analytical laboratories rely on these specialized compounds for rigorous impurity profiling, accurate method validation, and quantitative bioanalysis. By utilizing these materials for quality control and pharmacokinetic studies, researchers ensure the consistency and regulatory compliance necessary for the development of advanced antibody-drug conjugate treatments.